233 related articles for article (PubMed ID: 18523277)
1. A novel adenovirus expressing Flt3 ligand enhances mucosal immunity by inducing mature nasopharyngeal-associated lymphoreticular tissue dendritic cell migration.
Sekine S; Kataoka K; Fukuyama Y; Adachi Y; Davydova J; Yamamoto M; Kobayashi R; Fujihashi K; Suzuki H; Curiel DT; Shizukuishi S; McGhee JR; Fujihashi K
J Immunol; 2008 Jun; 180(12):8126-34. PubMed ID: 18523277
[TBL] [Abstract][Full Text] [Related]
2. Nasal Flt3 ligand cDNA elicits CD11c+CD8+ dendritic cells for enhanced mucosal immunity.
Kataoka K; McGhee JR; Kobayashi R; Fujihashi K; Shizukuishi S; Fujihashi K
J Immunol; 2004 Mar; 172(6):3612-9. PubMed ID: 15004163
[TBL] [Abstract][Full Text] [Related]
3. Notch-ligand expression by NALT dendritic cells regulates mucosal Th1- and Th2-type responses.
Fukuyama Y; Tokuhara D; Sekine S; Kataoka K; Markham JD; Irwin AR; Moon GH; Tokuhara Y; Fujihashi K; Davydova J; Yamamoto M; Gilbert RS; Fujihashi K
Biochem Biophys Res Commun; 2012 Feb; 418(1):6-11. PubMed ID: 22200492
[TBL] [Abstract][Full Text] [Related]
4. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
Hagiwara Y; McGhee JR; Fujihashi K; Kobayashi R; Yoshino N; Kataoka K; Etani Y; Kweon MN; Tamura S; Kurata T; Takeda Y; Kiyono H; Fujihashi K
J Immunol; 2003 Feb; 170(4):1754-62. PubMed ID: 12574339
[TBL] [Abstract][Full Text] [Related]
5. Potential roles of CCR5(+) CCR6(+) dendritic cells induced by nasal ovalbumin plus Flt3 ligand expressing adenovirus for mucosal IgA responses.
Fukuyama Y; Tokuhara D; Sekine S; Aso K; Kataoka K; Davydova J; Yamamoto M; Gilbert RS; Tokuhara Y; Fujihashi K; Kunisawa J; Yuki Y; Kiyono H; McGhee JR; Fujihashi K
PLoS One; 2013; 8(4):e60453. PubMed ID: 23565250
[TBL] [Abstract][Full Text] [Related]
6. A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity.
Fukuiwa T; Sekine S; Kobayashi R; Suzuki H; Kataoka K; Gilbert RS; Kurono Y; Boyaka PN; Krieg AM; McGhee JR; Fujihashi K
Vaccine; 2008 Sep; 26(37):4849-59. PubMed ID: 18625280
[TBL] [Abstract][Full Text] [Related]
7. The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia.
Kataoka K; Fujihashi K; Oma K; Fukuyama Y; Hollingshead SK; Sekine S; Kawabata S; Ito HO; Briles DE; Oishi K
Infect Immun; 2011 Jul; 79(7):2819-28. PubMed ID: 21536790
[TBL] [Abstract][Full Text] [Related]
8. Sendai virus fusion protein mediates simultaneous induction of MHC class I/II-dependent mucosal and systemic immune responses via the nasopharyngeal-associated lymphoreticular tissue immune system.
Kunisawa J; Nakanishi T; Takahashi I; Okudaira A; Tsutsumi Y; Katayama K; Nakagawa S; Kiyono H; Mayumi T
J Immunol; 2001 Aug; 167(3):1406-12. PubMed ID: 11466359
[TBL] [Abstract][Full Text] [Related]
9. Respiratory FimA-Specific Secretory IgA Antibodies Upregulated by DC-Targeting Nasal Double DNA Adjuvant Are Essential for Elimination of
Kataoka K; Kawabata S; Koyanagi K; Hashimoto Y; Miyake T; Fujihashi K
Front Immunol; 2021; 12():634923. PubMed ID: 33717178
[TBL] [Abstract][Full Text] [Related]
10. Non-toxic Stx derivatives from Escherichia coli possess adjuvant activity for mucosal immunity.
Ohmura-Hoshino M; Yamamoto M; Yuki Y; Takeda Y; Kiyono H
Vaccine; 2004 Sep; 22(27-28):3751-61. PubMed ID: 15315856
[TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production.
Yanagita M; Hiroi T; Kitagaki N; Hamada S; Ito HO; Shimauchi H; Murakami S; Okada H; Kiyono H
J Immunol; 1999 Mar; 162(6):3559-65. PubMed ID: 10092814
[TBL] [Abstract][Full Text] [Related]
12. A combination of Flt3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory-IgA immunity to Streptococcus pneumoniae in aged mice.
Fukuyama Y; King JD; Kataoka K; Kobayashi R; Gilbert RS; Hollingshead SK; Briles DE; Fujihashi K
J Immunol; 2011 Feb; 186(4):2454-61. PubMed ID: 21242514
[TBL] [Abstract][Full Text] [Related]
13. A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging.
Asanuma H; Zamri NB; Sekine S; Fukuyama Y; Tokuhara D; Gilbert RS; Fukuiwa T; Fujihashi K; Sata T; Tashiro M; Fujihashi K
Vaccine; 2012 Jan; 30(4):803-12. PubMed ID: 22100889
[TBL] [Abstract][Full Text] [Related]
14. Mucosal immunity of nasopharynx: an experimental study in TCR-transgenic (OVA23-3) mice.
Yamada T; Kataoka S; Ogasawara K; Ishimitsu R; Hashigucci K; Suzuki T; Kawauchi H
Rhinology; 2005 Sep; 43(3):190-8. PubMed ID: 16218512
[TBL] [Abstract][Full Text] [Related]
15. Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties.
Miller G; Pillarisetty VG; Shah AB; Lahrs S; DeMatteo RP
J Immunol; 2003 Apr; 170(7):3554-64. PubMed ID: 12646617
[TBL] [Abstract][Full Text] [Related]
16. Serum antibody response and nasal lymphoid tissue (NALT) structure in the absence of IL-4 or IFN-gamma.
Andoh A; Masuda A; Kumazawa Y; Kasajima T
Cytokine; 2002 Nov; 20(3):107-12. PubMed ID: 12453468
[TBL] [Abstract][Full Text] [Related]
17. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
[TBL] [Abstract][Full Text] [Related]
18. Fms-like tyrosine kinase 3 ligand regulates migratory pattern and antigen uptake of lung dendritic cell subsets in a murine model of allergic airway inflammation.
Shao Z; Makinde TO; McGee HS; Wang X; Agrawal DK
J Immunol; 2009 Dec; 183(11):7531-8. PubMed ID: 19917684
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
Liu Y; Huang H; Chen Z; Zong L; Xiang J
J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
[TBL] [Abstract][Full Text] [Related]
20. A nasal double DNA adjuvant system induces atheroprotective IgM antibodies via dendritic cell-B-1a B cell interactions.
Yoshimatsu H; Kataoka K; Fujihashi K; Miyake T; Ono Y
Vaccine; 2022 Feb; 40(8):1116-1127. PubMed ID: 35086743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
